Traws Revenue Per Share from 2010 to 2025

TRAW Stock   6.15  0.69  10.09%   
Traws Pharma Revenue Per Share yearly trend continues to be fairly stable with very little volatility. Revenue Per Share will likely drop to 0.01 in 2025. Revenue Per Share is the amount of revenue generated by Traws Pharma per share of stock, calculated by dividing total revenue by the average number of shares outstanding. View All Fundamentals
 
Revenue Per Share  
First Reported
2010-12-31
Previous Quarter
0.0124
Current Value
0.0118
Quarterly Volatility
31.5 K
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Traws Pharma financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Traws Pharma's main balance sheet or income statement drivers, such as Tax Provision of 0.0, Depreciation And Amortization of 15.6 K or Total Revenue of 193.2 K, as well as many indicators such as Price To Sales Ratio of 1.1 K, Dividend Yield of 0.0 or PTB Ratio of 30.16. Traws financial statements analysis is a perfect complement when working with Traws Pharma Valuation or Volatility modules.
  
Check out the analysis of Traws Pharma Correlation against competitors.
For more information on how to buy Traws Stock please use our How to Invest in Traws Pharma guide.

Latest Traws Pharma's Revenue Per Share Growth Pattern

Below is the plot of the Revenue Per Share of Traws Pharma over the last few years. It is the amount of revenue generated by a company per share of stock, calculated by dividing total revenue by the average number of shares outstanding. Traws Pharma's Revenue Per Share historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Traws Pharma's overall financial position and show how it may be relating to other accounts over time.
ViewLast Reported 0.0110 Years Trend
Slightly volatile
   Revenue Per Share   
       Timeline  

Traws Revenue Per Share Regression Statistics

Arithmetic Mean10,908
Geometric Mean12.49
Coefficient Of Variation288.52
Mean Deviation16,412
Median19.67
Standard Deviation31,473
Sample Variance990.6M
Range126.2K
R-Value(0.39)
Mean Square Error899.3M
R-Squared0.15
Significance0.13
Slope(2,583)
Total Sum of Squares14.9B

Traws Revenue Per Share History

2025 0.0118
2024 0.0124
2022 0.0108
2021 0.0134
2020 0.0199
2019 2.28
2018 4.47

About Traws Pharma Financial Statements

Traws Pharma investors use historical fundamental indicators, such as Traws Pharma's Revenue Per Share, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Traws Pharma. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Revenue Per Share 0.01  0.01 

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Traws Stock Analysis

When running Traws Pharma's price analysis, check to measure Traws Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Traws Pharma is operating at the current time. Most of Traws Pharma's value examination focuses on studying past and present price action to predict the probability of Traws Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Traws Pharma's price. Additionally, you may evaluate how the addition of Traws Pharma to your portfolios can decrease your overall portfolio volatility.